Comparison

AGT Antibody

Manufacturer ProSci
Category
Type Antibody Primary
Specific against Human, Mouse, Rat
Format Liquid
Applications WB, IF, IHC
Amount 50 uL
Host Rabbit
Item no. PRS-16-155-50uL
eClass 6.1 32160702
eClass 9.0 32160702
Available
Shipping
blue ice or RT
By Research Area
Apoptosis, Cancer, Cell Cycle
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 35-285 of human AGT (NP_000020.1).
Applications
WB: 1:500 - 1:2000

IHC: 1:50 - 1:100

IF: 1:50 - 1:100
Positive Control 1
HepG2
Predicted Molecular Weight
Observed: 53kDa
Purification
Affinity purification
Clonality
Polyclonal
Isotype
IgG
Conjugate
Unconjugated
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Storage Conditions
Store at -20˚ C. Avoid freeze / thaw cycles.
Disclaimer
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Modifications
None
Ncbi Official Symbol
AGT
Ncbi Gene Id #
183
User Note
Optimal dilutions for each application to be determined by the researcher.
Ncbi Official Symbol
AGT
Ncbi Official Full Name
Angiotensinogen
Ncbi Organism
Homo sapiens
Swissprot #
P01019
Background
The protein encoded by this gene, pre-angiotensinogen or angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease.
1st Image Caption
Western blot analysis of extracts of HepG2 cells, using AGT antibody (16-155) at 1:1000 dilution.
Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.
Lysates/proteins: 25ug per lane.
Blocking buffer: 3% nonfat dry milk in TBST.
Detection: ECL Basic Kit.
Exposure time: 30s.
2nd Image Caption
Immunohistochemistry of paraffin-embedded human liver cancer using AGT antibody (16-155) at dilution of 1:100 (40x lens).
3rd Image Caption
Immunohistochemistry of paraffin-embedded human placenta using AGT antibody (16-155) at dilution of 1:100 (40x lens).

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 uL
Available: In stock
available

Delivery expected until 6/6/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close